ZS Named Leader in Life Science R&D Data Platforms
ZS has been named a leader in IDC MarketScape's new report evaluating real-world data and evidence platforms for pharmaceutical R&D.
Global management consulting and technology firm ZS has been recognized as a leader in IDC MarketScape's latest report, which focuses on real-world data (RWD) and real-world evidence (RWE) platforms for pharmaceutical research and development.
The report assessed multiple vendors based on their capabilities in data platforms, technology solutions, and consulting services. ZS's strengths were identified as its comprehensive solutions and expertise that help pharmaceutical companies effectively leverage real-world data in both clinical and commercial operations.
IDC MarketScape's analysis highlights ZS's ability to integrate complex datasets and generate meaningful evidence from them. This assists companies in making data-driven decisions and improving patient outcomes.
ZS's recognition as a leader reflects the firm's commitment to the digital transformation of the life sciences industry and its role as a platform provider supporting the sector's evolving needs.